Novo Nordisk | NVO - 贸易债权人

金融业

DKK

DKK 90.92B

现金及等价物

DKK 21.13B

DKK 2.66B

DKK 31.89B

DKK 36.54B

DKK 146.38B

股息收益率

DKK 3.76

DKK 5.25B

DKK 37.37B

DKK 54.39K

EPS每股收益

DKK 0.96

股本和储备

DKK 33.81B

DKK 83.23B

债务利息支出

DKK 82.1M

DKK 6.05B

DKK 18.61B

DKK 143.99B

DKK 3.26B

DKK 6.96B

DKK 5.25B

普通股股本

DKK 4.43B

9.94

DKK 62.17B

DKK 12.13B

销售和管理费用

DKK 2.54B

DKK 51.35B

贸易债权人

DKK 2.23B

应收帐款人

DKK 17.56B

	贸易债权人	更改		日
ANI Pharmaceuticals	USD 73.83M		4.14M	2026-06
Aurora Cannabis	CAD 9.31M		58.72M	2026-03
Bausch Health Companies	USD 593M		0	2026-06
Bristol-Myers Squibb	USD 4.16B		76M	2026-06
Canopy Growth	CAD 34.82M		14.85M	2026-03
Corcept Therapeutics	USD 14.91M		18.4M	2026-06
Drreddys Laboratories	INR 22.36B		21.91B	2026-03
Eli Lilly	USD 6.11B		1.08B	2026-06
GlaxoSmithKline	GBP 14.34B		7M	2026-06
Merck	USD 3.83B		36M	2026-06
Nektar Therapeutics	USD 10.03M		744K	2026-03
Novartis	USD 4.26B		64M	2026-06
Novo Nordisk	DKK 14.59B		212M	2026-06
Novo Nordisk	DKK 2.23B		131.82B	2026-06
Pacira	USD 17.51M		3.5M	2026-06
Perrigo	USD 400.4M		34.4M	2026-06
Phibro Animal Health	USD 127.31M		2.33M	2026-06
Prestige Brands	USD 36.85M		14.06M	2026-06
Sanofi	EUR 23.6B		888M	2026-06
Supernus Pharmaceuticals	USD 5.59M		4.58M	2026-06
Zoetis	USD 452M		55M	2026-06